Sex Differences in the Density of Lipidic Plaque Materials: Insights From the REASSURE-NIRS MultiCenter Registry
Authors: Kataoka Yu , Nicholls Stephen J. , Puri Rishi , Kitahara Satoshi , Kiyoshige Eri , Nishimura Kunihiro , Murai Kota , Iwai Takamasa , Sawada Kenichiro , Matama Hideo , Honda Satoshi , Takagi Kensuke , Fujino Masashi , Yoneda Shuichi , Otsuka Fumiyuki , Nishihira Kensaku , Takamisawa Itaru , Asaumi Yasuhide , Noguchi Teruo 
Published: May 2023

Background:
Intravascular imaging has shown better response of coronary atheroma to statin-mediated lowering of low-density lipoprotein cholesterol in women. However, its detailed mechanism remains to be determined yet. Modifiability of coronary atheroma under lipid-lowering therapies is partly driven by lipidic plaque component. Given a smaller plaque volume in women, lipidic plaque features including their density may differ between sex. Therefore, the current study sought to characterize sex-related differences in the density of lipidic plaque.

Methods:
We analyzed 1429 coronary lesions (culprit/nonculprit lesions=825/604) in 758 coronary artery disease patients (men/women=608/150) from the REASSURE-NIRS multicenter registry (Revelation of Pathophysiological Phenotypes of Vulnerable Lipid-Rich Plaque on Near-Infrared Spectroscopy). Total atheroma volume at 4-mm segment, maximum 4-mm-lipid-core burden index, and lipid plaque density index (=maximum 4-mm-lipid-core burden index/total atheroma volume at 4-mm segment) on near-infrared spectroscopy/intravascular ultrasound imaging at culprit and nonculprit lesions were compared in men and women.

Results:

Statin and high-intensity statin were used in 72.4 (
P
=0.81) and 22.9% (
P
=0.32) of study subjects, respectively. Women exhibited a smaller adjusted total atheroma volume at 4-mm segment (culprit lesions: 50.3±0.4 versus 54.2±0.3mm
3
,
P
<0.001, nonculprit lesions: 31.5±3.0 versus 44.4±2.1mm
3
,
P
<0.001), whereas their adjusted maximum 4-mm-lipid-core burden index did not differ between sex (culprit lesions: 544.7±29.9 versus 501.7±19.1,
P
=0.11, nonculprit lesions: 288.8±26.7 versus 272.7±18.9,
P
=0.51). Furthermore, a greater adjusted lipid plaque density index was observed in women (culprit lesions: 18.2±0.9 versus 9.8±0.6,
P
<0.001, nonculprit lesions: 23.0±2.0 versus 7.8±1.4,
P
<0.001). These adjustments of total atheroma volume at 4-mm segment, maximum 4-mm-lipid-core burden index, and lipid plaque density index included age, body mass index, hypertension, dyslipidemia, diabetes, smoking, a history of myocardial infarction and chronic kidney disease, low-density lipoprotein cholesterol level, statin and ezetimibe use, vessel volume, and hospital unit. The aforementioned plaque features consistently existed in both acute coronary syndrome and stable coronary artery disease subjects.

Conclusions:
Women harbored greater condensed lipidic plaque features, accompanied by smaller atheroma volume. These observations indicate potentially better modifiable disease in women, which underscores the need to intensify their lipid-lowering therapies for further improving their outcomes.

Registration:

URL:
https://www.clinicaltrials.gov/
; Unique identifier: NCT04864171